131 related articles for article (PubMed ID: 17303418)
1. Convenient synthesis and in vitro pharmacological activity of 2-thioanalogs of salvinorins A and B.
Bikbulatov RV; Yan F; Roth BL; Zjawiony JK
Bioorg Med Chem Lett; 2007 Apr; 17(8):2229-32. PubMed ID: 17303418
[TBL] [Abstract][Full Text] [Related]
2. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.
Lee DY; Karnati VV; He M; Liu-Chen LY; Kondaveti L; Ma Z; Wang Y; Chen Y; Beguin C; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2005 Aug; 15(16):3744-7. PubMed ID: 15993589
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric synthesis of salvinorin A, a potent kappa opioid receptor agonist.
Scheerer JR; Lawrence JF; Wang GC; Evans DA
J Am Chem Soc; 2007 Jul; 129(29):8968-9. PubMed ID: 17602636
[No Abstract] [Full Text] [Related]
7. Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).
Béguin C; Richards MR; Li JG; Wang Y; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
Bioorg Med Chem Lett; 2006 Sep; 16(17):4679-85. PubMed ID: 16777411
[TBL] [Abstract][Full Text] [Related]
8. Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.
Yilmaz A; Crowley RS; Sherwood AM; Prisinzano TE
J Nat Prod; 2017 Jul; 80(7):2094-2100. PubMed ID: 28718638
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 2-alkyl-2-methoxymethyl-salvinorin ethers as selective κ-opioid receptor agonists.
Lee DY; Deng G; Ma Z; Xu W; Yang L; Liu J; Dai R; Liu-Chen LY
Bioorg Med Chem Lett; 2015 Oct; 25(20):4689-92. PubMed ID: 26330078
[TBL] [Abstract][Full Text] [Related]
10. Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.
Yan F; Roth BL
Life Sci; 2004 Oct; 75(22):2615-9. PubMed ID: 15369697
[TBL] [Abstract][Full Text] [Related]
11. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
12. Bioisosteric modification of salvinorin A, a potent and selective kappa-opioid receptor agonist.
Stewart DJ; Fahmy H; Roth BL; Yan F; Zjawiony JK
Arzneimittelforschung; 2006; 56(4):269-75. PubMed ID: 16724512
[TBL] [Abstract][Full Text] [Related]
13. O6C-20-nor-salvinorin A is a stable and potent KOR agonist.
Hirasawa S; Cho M; Brust TF; Roach JJ; Bohn LM; Shenvi RA
Bioorg Med Chem Lett; 2018 Sep; 28(16):2770-2772. PubMed ID: 29426768
[TBL] [Abstract][Full Text] [Related]
14. Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor.
Polepally PR; Huben K; Vardy E; Setola V; Mosier PD; Roth BL; Zjawiony JK
Eur J Med Chem; 2014 Oct; 85():818-29. PubMed ID: 25193297
[TBL] [Abstract][Full Text] [Related]
15. Salvinorin A: the "magic mint" hallucinogen finds a molecular target in the kappa opioid receptor.
Sheffler DJ; Roth BL
Trends Pharmacol Sci; 2003 Mar; 24(3):107-9. PubMed ID: 12628350
[TBL] [Abstract][Full Text] [Related]
16. N-methylacetamide analog of salvinorin A: a highly potent and selective kappa-opioid receptor agonist with oral efficacy.
Béguin C; Potter DN; Dinieri JA; Munro TA; Richards MR; Paine TA; Berry L; Zhao Z; Roth BL; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
J Pharmacol Exp Ther; 2008 Jan; 324(1):188-95. PubMed ID: 17951511
[TBL] [Abstract][Full Text] [Related]
17. Salvinorin A: allosteric interactions at the mu-opioid receptor.
Rothman RB; Murphy DL; Xu H; Godin JA; Dersch CM; Partilla JS; Tidgewell K; Schmidt M; Prisinzano TE
J Pharmacol Exp Ther; 2007 Feb; 320(2):801-10. PubMed ID: 17060492
[TBL] [Abstract][Full Text] [Related]
18. A review of salvinorin analogs and their kappa-opioid receptor activity.
Roach JJ; Shenvi RA
Bioorg Med Chem Lett; 2018 May; 28(9):1436-1445. PubMed ID: 29615341
[TBL] [Abstract][Full Text] [Related]
19. Identification of the molecular mechanisms by which the diterpenoid salvinorin A binds to kappa-opioid receptors.
Yan F; Mosier PD; Westkaemper RB; Stewart J; Zjawiony JK; Vortherms TA; Sheffler DJ; Roth BL
Biochemistry; 2005 Jun; 44(24):8643-51. PubMed ID: 15952771
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of new salvinorin A analogues incorporating natural amino acids.
Fichna J; Lewellyn K; Yan F; Roth BL; Zjawiony JK
Bioorg Med Chem Lett; 2011 Jan; 21(1):160-3. PubMed ID: 21115248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
